Clinical Trials Browser

Phase 4 × Has results × Carcinoma, Non-Small-Cell Lung × Clear all

NCT05219162 2025-09-11

GPS

Phase 4 Completed

182 enrolled 11 charts

Carcinoma, Non-Small-Cell Lung

NCT03715205 2025-08-29

Keynote-593

Phase 4 Completed

150 enrolled 14 charts

DermatologicThoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung, Melanoma

NCT03285763 2025-01-23

TAIL

Phase 4 Completed

619 enrolled 22 charts

Carcinoma, Non-Small-Cell Lung

NCT04078152 2024-12-20

WAVE

Phase 4 Completed

163 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung

NCT04511533 2024-04-05

Dacomitinib for Treatment of Patients in India With Metastatic Non Small Cell Lung Cancer With EGFR Activating Mutations

Phase 4 Completed

101 enrolled 11 charts

Carcinoma, Non-Small-Cell Lung

NCT04381494 2023-06-22

ON TRAX

Phase 4 Terminated

40 enrolled 17 charts

Carcinoma, Non-Small-Cell Lung, Pneumonia

NCT03853551 2021-06-03

Osimertinib Study in Indian Patients

Phase 4 Completed

60 enrolled 7 charts

Carcinoma, Non-Small-Cell Lung

NCT03444766 2020-12-04

Study of Nivolumab for Advanced Cancers in India

Phase 4 Completed

100 enrolled 12 charts

GenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Kidney Neoplasms

NCT02514174 2020-03-30

Afatinib Treatment for Patients With EGFR Mutation Positive NSCLC Who Are Age 70 or Older

Phase 4 Completed

25 enrolled 13 charts

Carcinoma, Non-Small-Cell Lung

NCT02208843 2018-12-17

Afatinib as Second-line Therapy for Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutation

Phase 4 Completed

60 enrolled 10 charts

Carcinoma, Non-Small-Cell Lung

NCT02151149 2018-09-24

ABOUND 70+

Phase 4 Completed

143 enrolled 25 charts

Adenocarcinoma, Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Lung Neoplasms, Carcinoma, Large Cell

NCT00666978 2017-11-13

Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking

Phase 4 Completed

540 enrolled 25 charts

GastrointestinalGenitourinaryGynecologicHead & NeckOther hematologic neoplasmThoracic

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Hypopharyngeal Neoplasms, Kidney Neoplasms, Laryngeal Neoplasms, Leukemia, Liver Neoplasms, Lung Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Tobacco Use Disorder, Leukemia, Myeloid, Acute, Small Cell Lung Carcinoma

NCT02695290 2017-09-18

Afatinib in EGFR+NSCLC (Recurrent or Stage IV) - Patients With Poor Performance Status (ECOG 2 or 3)

Phase 4 Terminated

1 enrolled 3 charts

Carcinoma, Non-Small-Cell Lung

NCT00949910 2016-10-05

An Expanded Access Program of Tarceva (Erlotinib) in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)

Phase 4 Completed

6,586 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung

NCT00365508 2016-03-29

Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking

Phase 4 Completed

642 enrolled 8 charts

GastrointestinalGenitourinaryGynecologicHead & NeckOther hematologic neoplasmThoracic

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Hypopharyngeal Neoplasms, Kidney Neoplasms, Laryngeal Neoplasms, Leukemia, Liver Neoplasms, Lung Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Tobacco Use Disorder, Tongue Neoplasms, Leukemia, Myeloid, Acute, Small Cell Lung Carcinoma

NCT00770588 2016-02-08

INFORM

Phase 4 Completed

296 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung

NCT02000531 2016-01-13

Progression Free Survival (PFS) Using Erlotinib for Non-Small-Cell Lung Cancer (NSCLC) in Chinese Population

Phase 4 Completed

45 enrolled 10 charts

Carcinoma, Non-Small-Cell Lung

NCT01196078 2015-07-27

A Study of Tarceva (Erlotinib) in Elderly Patients With Advanced Non-Small Cell Lung Cancer

Phase 4 Completed

114 enrolled 15 charts

Carcinoma, Non-Small-Cell Lung

NCT01287754 2015-06-02

A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Who Present EGFR Mutations

Phase 4 Completed

24 enrolled 11 charts

Carcinoma, Non-Small-Cell Lung

NCT01230710 2015-03-30

A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Following 4 Cycles of Platinum-based Chemotherapy Without Disease Progression

Phase 4 Completed

51 enrolled 10 charts

Carcinoma, Non-Small-Cell Lung

NCT00883675 2013-12-18

Safety Study of Adjuvant Docetaxel-Carboplatin Treatment for Resected Lung Cancer

Phase 4 Completed

133 enrolled 8 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00536107 2013-10-01

Study to Assess Safety/Tolerability/Efficacy of Gefitinib Versus Docetaxel in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Phase 4 Terminated

14 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung

NCT01020786 2013-08-27

A Study in Non-squamous Non Small Cell Lung Cancer in Asian Patients

Phase 4 Completed

109 enrolled 18 charts

Carcinoma, Non-Small-Cell Lung

NCT00608868 2012-09-28

SELINE

Phase 4 Completed

156 enrolled 14 charts

Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT00380718 2010-11-16

Chemotherapy for Patients With Non-Small Cell Lung Cancer

Phase 4 Completed

33 enrolled 26 charts

Carcinoma, Non-Small-Cell Lung